UNLIMITED TURBO BULL - PHARMING GROUP Stock

Certificat

DX33S

DE000SN7WR89

Real-time Euronext Paris 08:15:04 2024-04-18 EDT
0.12 ^EUR	-42.58%

Current month	-56.04%
1 month	-57.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PHARMING GROUP N.V.

Chart UNLIMITED TURBO BULL - PHARMING GROUP

Latest news about PHARMING GROUP N.V.

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K	04-25	PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards	04-25	AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K	04-24	PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	04-24	PU

More news

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	PHARMING GROUP N.V.
Issuer	Société Générale
	DX33S
ISIN	DE000SN7WR89
Date issued	2022-08-05
Strike	0.7535 €
Maturity	Unlimited
Parity	1 : 1
Emission price	0.23 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.74 €
Lowest since issue	0.12 €

Company Profile

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The Group is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.

Sector

More about the company